First described by Perou et al. (2000), breast cancer can be subdivided into four main clinical subtypes on the basis of gene expression profiles and receptor status (estrogen receptor [ER], progesterone receptor [PR], human epidermal growth factor receptor 2 [HER2]) and proliferation status as assessed by Ki67 [10]. Here, PGR is linked to breast carcinoma.